新型 RNA 療法有望幫助心臟在梗塞後修復
New RNA Therapy Could Help Hearts Heal After Attacks
心臟病發作通常會留下永久性損傷，因為成人心肌細胞難以再生。
A heart attack often leaves behind permanent damage because adult heart cells struggle to regenerate.
然而，心臟病學正經歷一場重大轉變，從單純的症狀管理轉向主動的組織修復。
However, a major shift in cardiology is moving from simple symptom management to active tissue repair.
近期核糖核酸（RNA）療法的突破帶來了希望，透過指導身體進行自我修復。
Recent breakthroughs in RNA therapy offer hope by instructing the body to heal itself.
哥倫比亞大學的研究人員首創了一種巧妙的「藥物工廠」方法。
Researchers at Columbia University have pioneered a clever 'drug factory' approach.
這種分子會傳輸至心臟，由一種酶將其轉化為心房利鈉肽（ANP），這能促進血管生長並減少疤痕。
This molecule travels to the heart, where an enzyme converts it into Atrial Natriuretic Peptide (ANP), which boosts blood vessel growth and reduces scarring.
同樣地，天普大學的團隊正利用改良的信使RNA（mRNA）來重新激活像PSAT1這樣的休眠發育基因，從而鼓勵心肌細胞增殖。
Similarly, teams at Temple University are using modified messenger RNA to reactivate dormant developmental genes like PSAT1, which encourages heart muscle cells to multiply.
同時，西達賽奈醫療中心（Cedars-Sinai）正在探索能標靶免疫細胞以清除碎片並降低發炎的「外泌體」。
Meanwhile, Cedars-Sinai is exploring 'exomers' that target immune cells to clear debris and lower inflammation.
這些創新代表了精準醫療的未來，我們得以避免風險高、具侵入性的手術。
These innovations represent a future of precision medicine where we avoid risky, invasive surgeries.
